Alpharix suspensie voor injectie in een voorgevulde spuit Trivalent griepvaccin (gefragmenteerd virion
Sponsors
GlaxoSmithKline Biologicals
Conditions
HumanInfluenza
Phase 2
A Phase 2a randomized, observer-blind, study to evaluate the immunogenicity and safety of mRNA-based multivalent seasonal influenza vaccine candidates in adults 18 years of age and older.
CompletedCTIS2025-522278-35-00
End: 2025-09-10Target: 150Updated: 2025-09-09
A Phase 2a randomized, observer-blind, study to evaluate the immunogenicity and safety of mRNA-based multivalent seasonal influenza vaccine candidates in adults 18 years of age and older
Active, not recruitingCTIS2025-522599-97-00
Start: 2025-10-30Target: 168Updated: 2026-01-19